Navigation Links
Following Heart Disease Guidelines Saves Lives, According to a Kaiser Permanente Abstract Presented at AHA Scientific Sessions

OAKLAND, Calif., Nov. 4 /PRNewswire/ -- Consistent implementation of proven Heart Disease guidelines can save lives, according to a Kaiser Permanente (KP) abstract, published this week at the American Heart Association Scientific Sessions in Orlando, Florida.

The researchers followed 598 patients with Acute Coronary Syndromes (ACS) admitted to Kaiser Permanente emergency departments in Northern California and examined whether they received any of six key interventions included in American College of Cardiology/American Heart Association Guidelines(1) that are known to decrease deaths from ACS. The results were then compared with data for ACS patients admitted to non-KP emergency departments, gathered by the National Registry of Myocardial Infarction (NRMI) and CRUSADE(2).

Overall, more Kaiser Permanente patients received the recommended therapies in every case. For example, 92 per cent of Kaiser Permanente patients with ACS were discharged with an ACE inhibitor(3) or angiotensin-receptor blocker (ARB)(4), recommended in the guidelines as an effective therapy for reducing mortality from heart attacks. By comparison, only 61 per cent of eligible patients in non-KP hospitals in the CRUSADE database and 55 per cent in the NRMI database received an ACE inhibitor or ARB. On admission, 97 per cent of eligible KP patients received beta blockers compared with 74 per cent in NRMI.

Kaiser Permanente Northern California has been systematically implementing the National Clinical Guidelines since the 1990s. Study co-author Eleanor Levin, MD explained that cardiologists and emergency physicians used the guidelines to develop protocols and standardized admit and discharge orders for treating ACS patients.

"Following the guidelines in KP Northern California has been so successful because four departments -- cardiology, quality, emergency medicine, and hospital-based specialists -- have worked closely together to implement protocols and orders for heart disease patients," said Dr. Levin. "We can achieve that kind of effective collaboration because we are an integrated health care organization. Our patients benefited immediately in a very real way -- the number of deaths caused by heart disease among KP Northern California members has been falling consistently since 1995. We hope that these results will encourage other health care organizations to improve implementation of the clinical guidelines and save lives," she said.

The six key therapies and interventions recommended by the National Clinical Guidelines are:

Once ACS is confirmed in the ED, the following medications should be


1. Aspirin, and

2. Beta Blockers

On discharge, patients should receive:

3. Aspirin

4. Beta Blockers, and

5. An ACE(4) inhibitor or ARB(5) and,

6. Advice on quitting smoking for patients who are smokers

About Kaiser Permanente

Kaiser Permanente, founded in 1945, is a non-profit integrated health care organization, with physicians, nurses and staff working in collaboration to provide high quality care to patients and to address the health care needs of communities served by the organization. The Kaiser Permanente Northern California Region serves more than 3.2 million members. It includes 6,000 physicians in The Permanente Medical Group (TPMG) and about 66,000 employees. The region has 19 major medical centers. Each year, Kaiser Permanente donates about $375 million to a variety of community programs and agencies in Northern California.


(1) ACC/AHA Guidelines are updated and published on the American Heart

Association web site.

(2) As of January 2007, CRUSADE (Can Rapid Risk Stratification of

Unstable Angina Patients Suppress Adverse Outcomes with Early

Implementation of ACC/AHA Guidelines) merged with the NRMI (National

Registry of Myocardial Infarction) to form the ACTION (Acute Coronary

Treatment and Intervention Outcomes Network) registry.

(3) ACE inhibitors, or inhibitors of angiotensin-converting enzyme, are a

group of pharmaceuticals that are used to treat high blood pressure

and congestive heart failure.

(4) An Angiotensin receptor blocker (ARB) is a medication that blocks the

action of angiotensin II, permitting the blood vessels to relax and

dilate, which lowers the blood pressure. ARBs have effects similar

to those of ACE inhibitors, and are often used when an ACE inhibitor

cannot be tolerated by patients.

SOURCE Kaiser Permanente
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Spurt in hospital admissions following football shoot-outs
2. Weight gain following smoking cessation not linked to Leptin
3. Anxiety following heart attacks not adequately managed
4. Reducing Disabilities By Following A Healthy Diet
5. Attention! Spells of momentary blindness following visual disturbance
6. Enhanced Gene Therapy Outcomes Following Latest Revolution And Refinement
7. Avenues to opened for medical tourists following relaxation of visa regulations
8. People seek reassurance in facemasks following threats of bird flu epidemic
9. Decline in Paternity Rates Following Treatment for Testicular Cancer
10. Death Of Woman Following Family Planning Operation Creates Panic
11. Boy Refused Compensation For HIV Infection Following Hospital Admission
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice ... "Film editors can give their videos a whole new perspective by using the ... of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
Breaking Medicine Technology: